English
English French German Portuguese Spanish Russian Japanese Korean Arabic Turkish Italian Indonesian Polish Hindi Dutch Malay Persian Thai Vietnamese
Leave Your Message
In/ Out Licensing Services

In/ Out Licensing Services

Bio-link Capital is a global R&D and licensing platform under clinical service center (CSC). Bio-link Capital is focusing on the fields of biomedical and high-end medical devices. Our pharmaceutical assets licensing channel reach the world, serving more than 3,000 global clients in the pharmaceutical field. Our employees and partners are located in Shanghai, Suzhou, Beijing, Taipei, Japan, Los Angeles, Boston, Germany, Switzerland, Canada, Australia and other regions. We are devoted to building the world's leading asset licensing platform to accelerate R&D, transactions and commercialization of novel drug, to benefit more patients. We have a mature business system structure, which can provide services including domestic and overseas pharmaceutical asset licesing transaction services, financial investment advisory, corporate merger and acquisition consulting, BD strategic consulting, product commercialization consulting, etc.

    Contact us
    product details
    product description

    description1

    description2

    • Biolink Capital

      Bio-link Capital is a global R&D and licensing platform under clinical service center (CSC).

    Bio-link Capital is focusing on the fields of biomedical and high-end medical devices. Our pharmaceutical assets licensing channel reach the world, serving for more than 3,000 global clients in the pharmaceutical field. Our employees and partners are located in Shanghai, Suzhou, Beijing, Taipei, Japan, Los Angeles, Boston, Germany, Switzerland, Canada, Australia and other regions. We are devoted to building the world's leading asset licensing platform to accelerate R&D, transactions, market access and commercialization of novel drug, to benefit more patients worldwide. We have a mature business system structure and network, which can provide services including domestic and overseas pharmaceutical asset licensing transaction services, financial investment advisory, corporate merger and acquisition consulting, BD strategic consulting, product commercialization consulting, etc.
    We provide one-stop BD solution for our clients, which include project evaluation, potential licensing analysis, technical support, legal support, transaction management, project coordination and contract negotiation.
    We have a professional BD team with rich experience, which can provide high-quality medical and pharmaceutical resources matching, in-depth industry research, BD strategic planning and cross-border asset licensing guidance. To develop customized BD decision-making strategies for licensor and licensee is our core output.
    As the external BD team of pharmaceutical or medical device clients, we are committed to helping clients carry out domestic and overseas asset licensing transactions, accurately identify market business opportunities, and provide the high-quality BD strategic decisions.

    We provide a range of regulatory services, including but not limit:

    • Assets in licensing/out licensing services:

      Pharmaceutical underlying asset evaluation and analysis

      Customized analysis of BD strategy and potential licensing deals

      Database and platform business promotion

      Transaction process management

      Due diligence, contract negotiation support

      Asset deal closure

    • BD strategic consulting service:

      Product market positioning analysis

      Technology value digging

      Revenue simulation and valuation analysis

      Specific product registration support

      Industry competitive landscape analysis

      Clinical registration pathway solution